$122.75
2.922.44%
At close: -
$122.75
0.000.00%
After Hours: 4:15 PM EDT
BioNTech reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of BioNTech using advanced sorting and filters.
Fiscal Quarter | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $0.89 | $-1.67 | 153.3 % |
Q2 | 2024-08-05 | $-3.62 | $-2.20 | -64.5 % |
Q1 | 2024-05-06 | $-1.42 | $-1.17 | -21.4 % |
Q3 | 2023-11-06 | $0.73 | $0.62 | 17.7 % |
Fiscal Quarter | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Q3 | 2024-11-04 | $1.37B | $639.12M | 114.0 % |
Q2 | 2024-08-05 | $138.56M | $170.40M | -18.7 % |
Q1 | 2024-05-06 | $203.74M | $460.50M | -55.8 % |
Q4 | 2024-03-20 | $1.59B | $1.99B | -20.0 % |
BioNTech (BNTX) is scheduled to report earnings on May 5, 2025. The last reported earnings were for reported on November 4, 2024 for Q3.
The Actual EPS was $0.89, which beat the estimate of $-1.67.
The Actual Revenue was $1.4B, which beat the estimate of $639.1M.
Browse earnings estimates, EPS, and revenue on all stocks.